Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Predictive factors and vi… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Predictive factors and virological response to interferon treatment in children with chronic hepatitis B.

Artikel i vetenskaplig tidskrift
Författare Ann Söderström
Magnus Lindh
Kajsa Ekholm
Nils Conradi
Peter Horal
Marie Krantz
Catharina Hultgren
Gunnar Norkrans
Publicerad i Scandinavian journal of infectious diseases
Volym 37
Nummer/häfte 1
Sidor 40-7
ISSN 0036-5548
Publiceringsår 2005
Publicerad vid Institutionen för invärtesmedicin, Avdelningen för infektionssjukdomar
Institutionen för laboratoriemedicin , Avdelningen för patologi
Institutionen för kvinnors och barns hälsa, Avdelningen för pediatrik
Institutionen för laboratoriemedicin, Avdelningen för klinisk virologi
Sidor 40-7
Språk en
Länkar dx.doi.org/10.1080/0036554041002603...
Ämnesord Adolescent, Antiviral Agents, adverse effects, therapeutic use, Child, Child, Preschool, DNA, Viral, blood, drug effects, Female, Hepatitis B virus, drug effects, Hepatitis B, Chronic, drug therapy, enzymology, pathology, Humans, Interferon-alpha, adverse effects, therapeutic use, Male, Neutropenia, chemically induced, Predictive Value of Tests
Ämneskategorier Medicin och Hälsovetenskap

Sammanfattning

Further knowledge about factors predicting response to interferon treatment for chronic hepatitis B in children is required, in particular as the benefits of therapy are uncertain. In the present study, baseline characteristics were related to virological and histological responses in 27 children given interferon-alpha for 24 weeks after steroid priming. HBe seroconversion was seen in 8 of 27 HBeAg positive patients and was accompanied by a sustained virological response (SR), with a median 4.1 log HBV DNA reduction. Pretreatment viraemia level was the only baseline parameter associated with SR. After 12 weeks of IFN (mid-treatment), viraemia was significantly reduced in all patients, with a median of 3.0 (range 0.6-5.2) log decline in SR compared with 0.6 (range -0.5-3.6) log decline in non-sustained responders (NSR). HBV DNA levels below 1 million copies/ml at week 12 predicted sustained response with a positive predictive value of 75% and a negative predictive value of 89%. During the latter half of the IFN treatment HBV DNA tended to increase by a mean of 0.4-0.5 log for all patient groups. Flares during IFN treatment were rare or mild as measured by ALT. Pretreatment anti-HBc IgM was associated with liver damage but not with response. Histological inflammation scores were improved in SR. Thus, pretreatment HBV DNA levels were associated with IFN response, and the virological response at week 12 predicts SR and may be useful in the decision to continue or modify therapy.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?